Cargando…
MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor
OBJECTIVE: To determine the prognostic value of the immunohistochemical evaluation of the multidrug resistance-associated protein 2 (MRP2) expression, together with its subcellular localization in primary fallopian tube carcinomas (PFTCs). METHODS: The immunohistochemical analysis was performed usin...
Autores principales: | Halon, Agnieszka, Materna, Verena, Donizy, Piotr, Matkowski, Rafal, Rabczynski, Jerzy, Lage, Hermann, Surowiak, Pawel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569580/ https://www.ncbi.nlm.nih.gov/pubmed/23135210 http://dx.doi.org/10.1007/s00404-012-2589-7 |
Ejemplares similares
-
MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver
por: Belinsky, M G, et al.
Publicado: (1999) -
Expression of MRP and cMOAT in Childhood Neuroblastomas and Malignant Liver Tumors and Its Relevance to Clinical Behavior
por: Matsunaga, Tadashi, et al.
Publicado: (1998) -
In vivo Cisplatin Resistance Depending upon Canalicular Multispecific Organic Anion Transporter (cMOAT)
por: Minamino, Tomoyoshi, et al.
Publicado: (1999) -
ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up
por: Halon, Agnieszka, et al.
Publicado: (2013) -
Augmented expression of Polo-like kinase 1 is a strong predictor of shorter cancer-specific overall survival in early stage breast cancer at 15-year follow-up
por: Donizy, Piotr, et al.
Publicado: (2016)